| Company Name | Date | Purpose |
|
Asston Pharmaceu
|
30-Mar-26
| Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 inter alia to consider and approve 1. To consider the appointment of Mr. Sumit Pawar as Chief Financial Officer of the Company.
2. To consider the appointment of Mr. Yashvardhan Tupe as Additional Non-Executive Director of the Company.
3. To consider the appointment of Mr. Sandip Sharma as Additional Non-Executive Independent Director of the Company.
4. To take note of the circular resolution passed by the Company for the appointment of a statutory auditor of the Company.
5. To consider and approve the date and Notice of the Extraordinary General Meeting of the Company. 6. Other incidental Matters |
|
Bazel Internatio
|
30-Mar-26
| Bazel International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 inter alia to consider and approve Intimation of Board Meeting held on Monday 30th March2026. |
|
Classic Leasing
|
30-Mar-26
| Classic Leasing & Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 inter alia to consider and approve Appointment of Directors and Other Business Matters. |
|
Commerl. Synbags
|
30-Mar-26
| Commercial Syn Bags Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2026 inter alia to consider and approve the following businesses along with other routine businesses:
1. To consider and approve conversion of warrants into the equity shares of the Company which was issued to the promoter group subject to the depositing the balance outstanding amount for conversion of warrants into the equity shares of the Company.
2. Other routine business items.
Commercial Syn Bags Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 ,inter alia, to consider and approve the following businesses along with other routine businesses: 1. To consider and approve conversion of warrants into the equity shares of the Company which was issued to the promoter group subject to the depositing the balance outstanding amount for conversion of warrants into the equity shares of the Company. 2. Other routine business items.
(As Per BSE Announcement Dated on 28.03.2026) |
|
Davangere Sugar
|
30-Mar-26
| To consider Fund Raising |
| Prev | Next |